tbuckley/cabot-search huggingface dataset:
Hippocrates revisited
Authors: S. A. Franzblau
Journal: JAMA (1977)

Ethics deals with right and wrong in human behavior. It indicates obligations and duties; it offers standards; it pronounces certain actions good, others bad. Medical ethics deals with right and wrong in the behavior of physicians when they are acting in their professional capacity. <i>Professional ethics takes the form of codes—the descriptions of actions deemed good or bad. Even though certain ethical principles might be regarded as universal, eg, the Golden Rule, codes of ethics usually relate to the cultural environment, and thus can vary according to time and place. Well known examples of codes of medical ethics, covering a range of 4,000 years, would include those of Hammurabi, Hippocrates, Maimonides, Percival, and the American Medical Association. There are many others. A recent book (M. B. Etziony</i>, The Physician's Creed: An Anthology of Medical Prayers, Oaths and Codes of Ethics Written and Recited by Medical Practitioners Through the Ages,<i>Springfield, Ill, Charles C. Thomas Publisher, 1973) made a fairly complete listing and can be highly recommended for the historically minded</i>. I wanted to refer to this book, but the two copies in the library of the AMA had "disappeared." Through interlibrary loan we tried to secure the book from two other medical libraries, only to find that their copies also had disappeared. One librarian, as if in excuse, said that a course in medical ethics was being given just then in the medical school. There is a certain piquancy in this situation—that medical students steal books on medical ethics during a course on medical ethics. This incident might serve as an introduction to Dr Franzblau's "revision" of the Hippocratic oath. He has propounded a set of values that seem to harmonize with our present cultural environment. The "revision" is not entirely tongue-in-cheek. Lester S. King, MD AMA
Adolescent medicine
Authors: R. W. Blum
Journal: JAMA (1990)

It was not long ago that the term "biopsychosocial" was linked to adolescent medicine in a somewhat pejorative manner to refer to those factors that were poorly understood but acknowledged to contribute to health status outcomes. Over the past few years there has been significant research that has increased our understanding of the interface between and among the biologic, behavioral, emotional, and social forces that influence adolescent health and well-being. This article will focus on two areas where significant advances have been made: the interface of biology and behavior, and an emerging understanding of the relationships between health status, health risk behavior, and achievement among adolescents. The emerging field of psychoneuroendocrinology has increasingly demonstrated hormonal influence on emotional processes.<sup>1</sup>Whereas the exact mechanisms have yet to be clearly elucidated, there is evidence that suggests that both androgens and estrogens influence brain functioning and, in turn, significantly influence behavior. From
SUBSTITUTION BEFORE EXAMINING BOARDS.
Journal: JAMA (2005)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
JAMA Journal Club
Journal: JAMA (1993)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Clonazepam
Authors: Jan Koch-Weser, Thomas R. Browne
Journal: New England Journal of Medicine (1978)

CLONAZEPAM, an antiepileptic drug approved in 1976 by the United States Food and Drug Administration (FDA) for treatment of certain types of seizures, is a benzodiazepine structurally related to chlordiazepoxide hydrochloride, diazepam and nitrazepam. Its chemical name is 5-(2-chlorophenyl)-l,3-dihydro-7-nitro-2H-l,4-benzodiazepin-2-one (Fig. 1).Clonazepam suppresses seizure activity in many animal models of epilepsy and many types of paroxysmal activity on the electroencephalogram of patients.1 Generalized electroencephalographic abnormalities are more readily suppressed than focal abnormalities.1 Clonazepam often limits the spread of discharge from a focal lesion while not suppressing the primary focus.1 These observations may be explained by the ability of benzodiazepines to . . .
I am currently half way through an SHO medical rotation, but am finding the demands of hospital hours and motherhood increasingly difficult. I am considering taking a 2-3 year career break, but, as a single mother, will need to work part time to support my baby and myself. I would be grateful if you could please offer some advice on any medically related jobs (or jobs I can do with a medical degree) that might be appropriate.
Authors: Ruth Chambers
Journal: BMJ (2005)

Have a career or related problem that needs answering? Can9t find the right person to point you in the right direction? Log on to the Advice Zone for reliable medical careers advice. You can post a question or see if one of our 300 advisers has already answered a similar question. Here is a selection of questions and answers posted on the site. <b>www.bmjcareers.com/advicezone</b>
The Retina: The Anatomy and the Histology of the Retina in Man, Ape and Monkey, Including the Consideration of Visual Functions, the History of Physiological Optics and the Histological Laboratory Technique
Journal: JAMA (1942)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
UNSUSPECTED FOREIGN BODIES IN THE STOMACH REVEALED BY AUTOPSY.
Journal: JAMA (2007)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Otolaryngology
Authors: Carlyle G. Flake
Journal: New England Journal of Medicine (1946)

THE following summarized articles, which appeared in the literature on otolaryngology during 1945, were selected as being of general interest.The Ear Fenestration Operation Fenestration of the labyrinth for the purpose of providing better hearing in otosclerosis is now a well established and widely performed operative procedure. Although many advances have been made in the technic of operation and the proper selection of patients, closure of the fistula by the formation of new bone remains the current postoperative bugbear.With the latest modification in his technic, Lempert1 believes that he has solved the two major causes of previous failure: osteogenic . . .
California battles perinatal hepatitis B
Authors: P. Gunby
Journal: JAMA (1982)

California is campaigning to prevent perinatal transmission of hepatitis B virus (HBV). The professional education effort began in February because, according to James Chin, MD, of the California Department of Health Services, Berkeley, a conservative estimate is that "several thousand perinatally acquired HBV infections" occur annually in that state. That may be almost as many cases as in the other 49 states put together, he says. Why so many in California? According to Chin, chief of the department's infectious disease section, the HBV-carrier prevalence rate among white adults in the United States is around 0.3%. But it may be as high as 20% among immigrants from Asia and the Pacific Basin and among native-born persons of Asian, Polynesian, Micronesian, or Eskimo ancestry. California has a larger number of persons from the latter high-risk groups—more than 1 million total— than do other states. Thus, California's health department is urging hepatitis B
AMA-RPS Organizational Development for 1992—The Issues
Journal: JAMA (1992)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Reply to Can Lu and Xiao Guan’s Letter to the Editor re: Marko Babjuk. Are the Role of Surgery and its Complications Sufficiently Focused in the Era of Perioperative Systemic Treatments? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.01.022
Authors: Marko Babjuk
Journal: European Urology (2020)
Tuberculosis: Cause of Emphysema
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A randomized phase III trial of 1 month versus 1 year adjuvant high-dose interferon alfa-2b in patients with resected high risk melanoma
Authors: H. Gogas, U. Dafni, D. Bafaloukos, A. Polyzos, G. Kokkalis, H. P. Kalofonos, G. Fountzilas, D. Skarlos, D. Tsoutsos, D. Pectasides
Journal: Journal of Clinical Oncology (2007)

8505 Background: High dose IFNa regimen as reported in E1684 was unique for the incorporation of an induction phase of maximally-tolerated dosages of IV therapy for the initial 4 weeks. This is the only trial that has shown prolongation of overall survival and disease-free survival in comparison to observation. Analysis of the hazard curves for DFS and OS in E1684 reveal early and durable separation of the high-dose and observation arms suggesting that the induction phase may represent a critical component of the high-dose regimen, although this has not been tested prospectively. Methods: We conducted a prospective randomized study of IV induction therapy vs a full year of high-dose IFN with primary endpoints of DFS and OS for stage IIB, IIC and III melanoma patients within 56 days of curative surgery. Patients were randomized to receive IFN alfa-2b 15×10 6 U/m 2 IV × 5/7 days weekly × 4 weeks (arm A) versus the same regimen followed by 10×10 6 U(flat dose) SC 3 times a week for 48 weeks (arm B). The proposed treatment would be considered at least as good as the conventional treatment, if the relapse rate at 3 years from study entry is at most 15% higher in the former arm (power 85%, one-sided test a=0.05, required sample size: 340). Results: Between 1998 and 2004, 364 patients were enrolled (355 eligible: 178 arm A and 177 arm B). Patients′ and tumor characteristics were well balanced between the two arms. At a median follow up of 51 months (95% CI 46–55), the median DFS is 32 months vs 31 months (p=0.836) and the median OS is 61 months vs 63 months (p=0.444). Eleven patients discontinued treatment in arm A and 54 in arm B. The discontinuation rate is significantly higher in group B (p&lt;0.001), possibly due to the longer duration. Reasons for discontinuation were disease progression (69%) and toxicity (19%). Patients in arm B had more grade 3–4 hematologic, constitutional and neurologic toxicity. Conclusions: There are no significant differences in OS and DFS between the regimen of 1 month and 1 year treatment tested. [Table: see text]
GLYCURESIS VERSUS GLYCOSURIA
Journal: JAMA (1918)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Biomedical ethics
Authors: L. Walters
Journal: JAMA (1985)

An overview is provided of bioethical issues recently under discussion in the United States. Six topics dominated the field in 1984 and early 1985: human gene therapy; in vitro fertilization and research with human embryos; appropriate care for dying patients, both adults and newborns; organ transplantation; resource allocation and payment for health care services; and the role of hospital ethics committees in medical decision making. Walters focuses on three of these topics: (1) the issuing of standards for somatic-cell gene therapy; (2) developments in the death and dying arena, including state living will legislation, the emergence of a viewpoint that artificial nutrition and hydration are not qualitatively different from respiratory life-support systems, and federal efforts to regulate appropriate treatment for handicapped newborns; and (3) the growing support among medical organizations for hospital ethics committees.
" Children of the Siege."
Journal: JAMA (1884)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
SOCIETY NEWS.
Authors: Hal Foster
Journal: JAMA (1896)

<b>The Northwestern Ohio Medical Society</b>held its fifty-second meeting at Defiance, December 10 and 11. The following officers were elected: President, Dr. Joseph Sager of Celina; vice-presidents, Drs. James A. Duncan of Toledo and R. D. Dihle of Lima; secretary, Dr. J. P. Baker of Findlay; treasurer, Dr. L. M. Gehrett of Deshler. Dr. J. P. Baker of Findlay read an elaborate paper on "Treatment of Diphtheria by Antitoxin," in which he reported twenty-nine cases with the following results: Number of cases treated with antitoxin 23, number of cases of laryngeal invasion 6, number of deaths 1; 9 cases received antitoxin first day, 4 the second day, 4 the third day, 2 the fourth day, 1 the fifth day, 1 case, stage of disease indefinite; 13 cases received one injection, 6 received two injections, 1 received three injections, 1 received four injections. The antitoxin was supplemented by protonuclein combined with
Mycobacterium bovis meningitis
Authors: P. G. Jones
Journal: JAMA (1982)

AN UNUSUAL case of mycobacterial meningitis caused by<i>Mycobacterium bovis</i>is reported. Sparse growth of the initial isolate, obtained from the CSF, raised the possibility of<i>M bovis</i>or resistant<i>M tuberculosis</i>infection. Enhanced growth on a glycerol-free medium and results of biochemical testing led to the identification of<i>M bovis</i>. <h3>Report of a Case</h3> A 63-year-old male dentist was admitted to a community hospital on Aug 20, 1980, after ten days of headache, stiff neck, and photophobia. He was confused, but there were no focal neurological findings. Cerebrospinal fluid analysis disclosed 290 WBCs per cubic millimeter, with 90% lymphocytes and 10% neutrophils. The CSF protein level was 193 mg/dL and the glucose level was 22 mg/dL, with a serum glucose level of 105 mg/dL. He did not respond to administration of intravenous penicillin G potassium, 24 million units/ day, became more confused, and was transferred to the University of